Back to results
US 2025/0051355 A1Published application
Compounds, compositions, and methods
AssigneeAconcagua Bio, Inc.
InventorsHui LEI, Cui LI, Chunliang LU, Ding XUE, Haizhen ZHANG, Zhuming ZHANG, Evelyne HOUANG, Jian LIU, Zhe NIE, Anatoly RUVINSKY, Eric THERRIEN
Life of this patent
Estimating the term…
Abstract
The present disclosure provides compounds for modulating calcitonin receptor and/or amylin receptor activity, as well as pharmaceutical compositions comprising the compounds disclosed herein. Also provided are methods for treating a calcitonin receptor and/or amylin receptor associated disease or disorder.
Claims29
A compound of Formula I:
- or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or solvate thereof, wherein:
- A is C1-6 alkylene, C2-6 alkenylene, C2-6 alkynylene, C3-10 cycloalkylene, heterocyclylene, arylene, or heteroarylene;
- wherein the C1-6 alkylene, C2-6 alkenylene, C2-6 alkynylene, C3-10 cycloalkylene, heterocyclylene, arylene, or heteroaryl of A is independently optionally substituted with one to five ZA;
- Ring B is a 5- or 6-membered heteroaryl optionally substituted with one to three RB;
- each RB is independently selected from halo, hydroxy, —NH2, cyano, C1-3 alkyl, C1-3 haloalkyl, C1-3 alkoxy, and C1-3 haloalkoxy;
- wherein each C1-3 alkyl of RB is independently optionally substituted with —NH2, —NHC1-3 alkyl, —N(C1-3 alkyl)2, hydroxy, or C1-3 alkoxy;
- Y1a is —C(O)—, —C(S)—, —S(O)2—, —S(O)(NR)—, or —P(O)R)—;
- Y2 is —O—, —S—, —NR2— or —C(R2)2—;
- wherein the bond between Y1a and Y2 is a single bond;
- and
- Y3 is —NR8—, —O—, —S—, —C(R3)2—, —NR8—C(R3)2—, —O—C(R3)2—, —S—C(R3)2—, —C(R3a)2—C(R)2—, —C(R3a)2—C(R3a)2—C(R3a)2—, or —CR3═CR3—;
- or
- Y1 is —C(O)—, —C(S)—, —S(O)2—, —S(O)(NR6)—, or —P(O)R7)—;
- Y2 is —N— or —CR2—, and
- Y3 is —N— or —CR3—;
- wherein the bond between Y2 and Y3 is a double bond;
- or
- Y1 is —N— or —CR1—;
- Y2 is —N— or —CR2—;
- wherein the bond between Y1a and Y2 is a double bond;
- and
- Y3 is —NR—, —O—, or —S—;
- provided that the ring comprising Y1, Y2, and Y3 contains at least one heteroatom;
- L1a is C1-3 alkylene, C2-3 alkenylene, C2-3 alkynylene, C1-3 heteroalkylene, C3-6 cycloalkylene, or 4-6 membered heterocyclylene;
- wherein the C1-3 alkylene, C2-3 alkenylene, C2-3 alkynylene, C1-3 heteroalkylene, C3-6 cycloalkylene, or 4-6 membered heterocyclylene of L1a is independently optionally substituted with one to five substituents independently selected from halo, oxo, hydroxy, cyano, C1-3 alkyl, C1-3 haloalkyl, C1-3 alkoxy, and C1-3 haloalkoxy;
- L2 is a bond, —O—, —S—, —NRa—, —C(O)—, —C(O)O—, —OC(O)—, —OC(O)O—, —C(O)NR2a—, —NR2aC(O)—, —OC(O)NR2a—, —NR2aC(O)O—, —NR2aC(O)NR2b—, —S(O)—, —S(O)2—, —S(O)NR2a—, —S(O)2NR2a—, —NR2aS(O)—, —NR2aS(O)2—, —NR2S(O)NR2b—, —NR2aS(O)2NR2b—, C1-6 alkylene, C2-4 alkenylene, C2-6 alkynylene, C1-6 heteroalkylene, C3-6 cycloalkylene, 4-6 membered heterocyclylene, or 5 membered heteroarylene;
- wherein the C1-3 alkylene, C2-3 alkenylene, C2-3 alkynylene, C1-3 heteroalkylene, C3-6 cycloalkylene, 4-6 membered heterocyclylene, or 5 membered heteroarylene of L2 is independently optionally substituted with one to five substituents independently selected from halo, oxo, hydroxy, cyano, —NH2, —NHC1-3 alkyl,
- —N(C1-3 alkyl)2, C1-3 alkyl, C1-3 haloalkyl, C1-3 alkoxy, and C1-3 haloalkoxy;
- R7 is hydrogen, halo, hydroxy, cyano, C1-3 alkyl, C2-3 alkenyl, C2-3 alkynyl, C1-3 haloalkyl, C1-3 alkoxy, or C1-3 haloalkoxy;
- each R2 is independently hydrogen, C1-3 alkyl, C2-3 alkenyl, C2-3 alkynyl, C1-3 haloalkyl, C3-6 cycloalkyl, phenyl, 4 to 6-membered heterocyclyl, or 5 to 6-membered heteroaryl;
- wherein each C1-3 alkyl, C2-3 alkenyl, C2-3 alkynyl, C1-3 haloalkyl, C3-6 cycloalkyl, phenyl, 4 to 6-membered heterocyclyl, or 5 to 6-membered heteroaryl of R2 is independently optionally substituted with one to five substituents independently selected from halo, hydroxy, cyano, C1-3 alkyl, C2-3 alkenyl, C2-3 alkynyl, C1-3 haloalkyl, C1-3 alkoxy, or C1-3 haloalkoxy;
- or R2 and any one or two of R1, R3, R3a, R6, R7, and R8, together with the atoms to which they are attached, form a C3-10 cycloalkyl, heterocyclyl, or heteroaryl;
- wherein the C3-10 cycloalkyl, heterocyclyl, or heteroaryl is optionally substituted with one to five Z2;
- each R2a and R2b is independently hydrogen, C1-6 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-6 haloalkyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl;
- wherein each C1-6 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-6 haloalkyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl of R2a and R2b is independently optionally substituted with one to five Z2a;
- or R2a and R2b are taken together with the atoms to which they are attached to form heterocyclyl independently optionally substituted by one to five Z2a;
- each R3 is independently hydrogen, hydroxy, —NR3bR3c, C1-6 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-6 alkoxy, C1-6 heteroalkyl, C1-6 haloalkyl, C1-6 haloalkoxy, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl;
- wherein each C1-6 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-6 alkoxy, C1-6 heteroalkyl, C1-6 haloalkyl, C1-6 haloalkoxy, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl of R3 is independently optionally substituted with one to five Z3;
- or two R3, together with the atom(s) to which they are attached, form a C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl;
- wherein the C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one to five Z3;
- or two R3, together with the carbon atom to which both are attached, form an oxo;
- each R3 is independently hydrogen, C1-6 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl;
- wherein each C1-6 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl of R3a is independently optionally substituted with one to five Z3a;
- or two R3a, together with the atom(s) to which they are attached, form a C3-10 cycloalkyl, heterocyclyl, or heteroaryl;
- wherein the C3-10 cycloalkyl, heterocyclyl, or heteroaryl is optionally substituted with one to five Z3;
- or two R3a, together with the carbon atom to which both are attached, form an oxo;
- R3b and R3c are each independently hydrogen, C1-6 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-6 haloalkyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl;
- wherein each C1-6 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-6 haloalkyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl of R3b and R3c is independently optionally substituted with one to five substituents independently selected from halo, hydroxy, cyano, C1-3 alkyl, C1-3 haloalkyl, C1-3 alkoxy, and C1-3 haloalkoxy;
- or R3b and R3c are taken together with the nitrogen atom to which they are attached to form a heterocyclyl optionally substituted with one to five Z3b;
- R4 is C1-6 alkyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl;
- wherein the C1-6 alkyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl of R4 is independently optionally substituted with one to five Z4;
- R5 is hydrogen, halo, hydroxy, amino, cyano, C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl;
- wherein the C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl of R5 is independently optionally substituted with one to five Z5;
- R6 is hydrogen, C1-3 alkyl, C1-3 haloalkyl, C3-6 cycloalkyl, or 4 to 6-membered heterocyclyl;
- wherein the C1-3 alkyl, C1-3 haloalkyl, C3-6 cycloalkyl, or 4 to 6-membered heterocyclyl is optionally substituted with one to five substituents independently selected from halo, oxo, hydroxy, cyano, C1-3 alkyl, C1-3 haloalkyl, C1-3 alkoxy, and C1-3 haloalkoxy;
- R7 is hydroxy, C1-3 alkoxy, C1-3 haloalkoxy, C1-3 alkyl, or C1-3 haloalkyl;
- R8 is hydrogen, —S(O)2—C1-3 alkyl, —S(O)2—C1-3 haloalkyl, C1-3 alkyl, C1-3 haloalkyl C3-6 cycloalkyl, or 4 to 6-membered heterocyclyl;
- wherein the —S(O)2—C1-3 alkyl, —S(O)2—C1-3 haloalkyl, C1-3 alkyl, C1-3 haloalkyl C3-6 cycloalkyl, or 4 to 6-membered heterocyclyl of R7 is optionally substituted with one to five substituents independently selected from halo, oxo, hydroxy, cyano, C1-3 alkyl, C1-3 haloalkyl, C1-3 alkoxy, and C1-3 haloalkoxy;
- each ZA, Z2, Z2a, Z3, Z3a, Z3b, Z4, and Z5;
- is independently halo, cyano, nitro, oxo, C1-6 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-6 haloalkyl, C3-10 cycloalkyl, heterocyclyl, aryl, heteroaryl, -L-H, -L-C1-6 alkyl, -L-C2-6 alkenyl, -L-C2-6 alkynyl, -L-C1-6 haloalkyl, -L-C3-10 cycloalkyl, -L-heterocyclyl, -L-aryl, or -L-heteroaryl;
- wherein each C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl of ZA, Z2, Z2a, Z3, Z3a, Z3b, Z4, and Z5 are each independently optionally substituted with one to five Z1a;
- each L is independently —O—, —S—, —NR20—, —C(O)—, —C(O)O—, —OC(O)—, —OC(O)O—, —C(O)NR20—, —NR20C(O)—, —OC(O)NR20—, —NR20C(O)O—, —NR20C(O)NR21—, —S(O)—, —S(O)2—, —S(O)NR20—, —S(O)2NR20—, —NR20S(O)—, —NR20S(O)2—, —NR20S(O)NR21—, or —NR20S(O)2NR21—;
- each R20 and R21 is independently hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl;
- wherein each C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl of R20 and R21 is independently optionally substituted with one to five Z1a;
- or an R20 and R21 are taken together with the atoms to which they are attached to form heterocyclyl independently optionally substituted by one to five Z1a;
- and
- each Z1a is independently halo, hydroxy, cyano, nitro, oxo, —SH, —NH2, —NH—C1-6 alkyl, —N(C1-6 alkyl)2, —S—C1-6 alkyl, C1-6 alkoxy, C1-6 alkyl, C2-6 alkenyl, C2-4 alkynyl, C1-6 haloalkyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl;
- wherein each —NH—C1-6 alkyl, —N(C1-6 alkyl)2, —S—C1-6 alkyl, C1-6 alkoxy, C1-6 alkyl, C2-4 alkenyl, C2-6 alkynyl, C1-6 haloalkyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl of Z1a is independently optionally substituted with one to five substituents independently selected from C1-6 alkyl, oxo, halo, hydroxy, and cyano;
- provided that when Ring B is unsubstituted thiophenyl, then -A-L2-R5 is not unsubstituted thiophenyl or unsubstituted phenyl.
66 more elements
A compound, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or solvate thereof, as shown in Table 1 or Table 2.
Dependencies are inferred from the claim text.